Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BH Lean Drop is an unirradiated medical cannabis flower product developed and produced by DEMECAN in Germany. It is derived from the Sunset Sherbet cultivar, an Indica-dominant hybrid strain resulting from a cross between Girl Scout Cookies and Pink Panties. The product features a cannabinoid profile of approximately 22.0% tetrahydrocannabinol (THC) and less than 1.0% cannabidiol (CBD). It is prescribed for the management of conditions such as chronic pain, stress, and headaches, exerting its therapeutic effects primarily through the activation of cannabinoid receptors in the endocannabinoid system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BH Lean Drop.